Novo Nordisk ADR (NYSE: NVO) is -20.75% lower on its value in year-to-date trading and has touched a low of $57.00 and a high of $148.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVO stock was last observed hovering at around $68.20 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $68.17, the stock is 2.95% and 0.88% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.18 million and changing -0.04% at the moment leaves the stock -29.82% off its SMA200. NVO registered -48.71% loss for a year compared to 6-month loss of -31.70%. The firm has a 50-day simple moving average (SMA 50) of $67.5726 and a 200-day simple moving average (SMA200) of $97.13245.
The stock witnessed a 11.21% gain in the last 1 month and extending the period to 3 months gives it a -22.60%, and is 3.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.92% over the week and 2.76% over the month.
Novo Nordisk ADR (NVO) has around 76302 employees, a market worth around $229.47B and $43.59B in sales. Current P/E ratio is 20.22 and Fwd P/E is 14.47. Profit margin for the company is 34.52%. Distance from 52-week low is 19.60% and -53.99% from its 52-week high. The company has generated returns on investments over the last 12 months (44.25%).
The EPS is expected to grow by 25.94% this year
1811.0 institutions hold shares in Novo Nordisk ADR (NVO), with institutional investors hold 9.88% of the company’s shares. The shares outstanding are 3.37B, and float is at 3.37B with Short Float at 0.75%. Institutions hold 9.88% of the Float.
The top institutional shareholder in the company is JENNISON ASSOCIATES LLC with over 21.22 million shares valued at $3.03 billion. The investor’s holdings represent 0.476 of the NVO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 19.49 million shares valued at $2.78 billion to account for 0.4373 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 14.61 million shares representing 0.3272 and valued at over $2.09 billion, while BANK OF AMERICA CORP /DE/ holds 0.3183 of the shares totaling 14.19 million with a market value of $2.03 billion.
